Back to search
FDAFDA · Food and drugs·Recall number Z-2374-2015

SEDASYS Computer-Assisted Personalized Sedation System, SEDPRU01. An integrated physiological monitoring and drug delivery system intended to provide physician-led teams with a means of administering 1% propofol (10 mg/mL) injectable emulsion to sedate patients > 18 (ASA I-II) undergoing esophagogastroduodenoscopy (EGD) and colonoscopy procedures. Intended to provide physician-led teams with a means of administering 1% propofol (10 mg/mL) injectable emulsion to sedate patients > 18 (ASA I-II) undergoing esophagogastroduodenoscopy (EGD) and colonoscopy procedures.

Published September 2, 2015 · Recall initiated: May 13, 2015

Summary

FDA records medical device Class I recall Z-2374-2015, published September 2, 2015 and initiated May 13, 2015. Recalling firm: Ethicon Endo-Surgery Inc; Status: Terminated; Reported quantity: 14 units; Lot: Model #SEDPRU01. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Ethicon has found that disinfecting methods not specified in the Instructions For Use (IFU) have led to the degradation of the plastic material of the SEDASYS System Control Unit.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Ethicon Endo-Surgery Inc
Distributor
Nationwide Distribution including OH, RI, TX & WA.
Lot
Model #SEDPRU01
Risk classification
Class I
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was SEDASYS Computer-Assisted Personalized Sedation System, SEDPRU01. An integrated physiological monitoring and drug delivery system intended to provide physician-led teams with a means of administering 1% propofol (10 mg/mL) injectable emulsion to sedate patients > 18 (ASA I-II) undergoing esophagogastroduodenoscopy (EGD) and colonoscopy procedures. Intended to provide physician-led teams with a means of administering 1% propofol (10 mg/mL) injectable emulsion to sedate patients > 18 (ASA I-II) undergoing esophagogastroduodenoscopy (EGD) and colonoscopy procedures. recalled?

Yes. FDA published recall Z-2374-2015 on September 2, 2015. Reported hazard: Ethicon has found that disinfecting methods not specified in the Instructions For Use (IFU) have led to the degradation of the plastic material of the SEDASYS System Control Unit.

What should I do if I have this product?

Voluntary: Firm initiated · Letter